EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Electrophysiologic effects of bepridil in normal and infarcted canine myocardium


Journal of Cardiovascular Pharmacology 8(5): 957-966
Electrophysiologic effects of bepridil in normal and infarcted canine myocardium
The electrophysiologic effects of bepridil, 10 mg/kg i.v., were determined in normal noninfarcted and in infarcted ventricular myocardium in 8 urethane-anesthetized dogs 4-6 days after anterior myocardial infarction. At drive cycle lengths of 400 and 333 ms, bepridil significantly increased relative (RRP) and effective (ERP) refractory periods in both normal ventricular tissue (mean increases, RRP 7-14%, ERP 5-6%, p less than 0.05-0.01) and in infarcted ventricular tissue (mean increases, RRP 12-15%, ERP 13-14%, p less than 0.01). Bepridil also selectively prolonged the local activation delay in infarcted ventricular myocardium (mean increases 37.5-45.1%, p less than 0.01), while ventricular excitation thresholds were not altered by bepridil in either normal or infarcted myocardium. Before bepridil administration, programmed ventricular stimulation initiated sustained ventricular tachycardias in 6 of the 8 postinfarction dogs tested. After bepridil, 2 of the 6 previously responsive animals were rendered noninducible, 3 animals responded to programmed stimulation with nonsustained tachyarrhythmias of relatively slower rates, and the one remaining dog responded with sustained ventricular tachycardia (VT). These data suggest that increases in refractoriness in both normal noninjured and in ischemically injured ventricular tissue, with a selective delay in conduction in ischemically injured tissue, contribute to the antiarrhythmic actions of bepridil in the setting of myocardial infarction.


Accession: 005349289

PMID: 2429097

DOI: 10.1097/00005344-198609000-00012



Related references

Effects of bepridil and lidocaine on the intraventricular condition in acutely ischemic and infarcted canine myocardium. Naunyn-Schmiedeberg's Archives of Pharmacology 342(6): 683-690, 1990

Effects of bepridil and lidocaine on the intraventricular conduction in acutely ischaemic and infarcted canine myocardium. Naunyn-Schmiedeberg's Archives of Pharmacology 342(6): 683-690, 1990

Electrophysiologic effects of EO47/1 on Purkinje fibers from normal and infarcted canine hearts. FASEB Journal 9(3): A602, 1995

Antiarrhythmic and electrophysiologic effects of bepridil in chronically infarcted conscious dogs. Journal of Pharmacology and Experimental Therapeutics 234(1): 72-80, 1985

Electrophysiological actions of bepridil on normal and infarcted canine purkinje fibers. European Heart Journal 8(ABSTR SUPPL 2): 81, 1987

Effects of procainamide on strength-interval relations in normal and chronically infarcted canine myocardium. American Journal of Cardiology 47(6): 1223-1232, 1981

Effects of sotalol on monophasic action potentials in normal and infarcted canine ventricular myocardium. European Heart Journal 12(ABSTR SUPPL): 45, 1991

Effects of bepridil on the electrophysiologic properties of isolated canine and rabbit myocardial fibers. American Heart Journal 111(2): 271-279, 1986

Electrophysiologic properties of myocytes from normal canine epicardium and the epicardial border zone in the infarcted heart. Circulation 80(4 SUPPL 2): II500, 1989

Quantitative integrated backscatter characteristics in the normal and infarcted canine myocardium. Journal of Cardiography 16(4): 799-808, 1986